v3.26.1
Restatement of Previously Issued Financial Statements - Schedule of Restated Audited Consolidated Statement of Equity (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2025
 [1]
Mar. 31, 2025
Dec. 31, 2024
Mar. 31, 2025
Jun. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2023
Schedule of Restated Audited Consolidated Statement of Equity [Line Items]                
Additional paid-in capital, issuance of shares upon exercise of warrants for cash       $ 38,514   $ 38,433 $ 2,937  
Issuance of common shares for loan settlement             1,300  
Issuance of new shares for cash             14,637  
Net loss attributable to common stockholders           (49,073)    
Net loss attributable to common stockholders $ (1,650) $ (555) [1] $ (29,544) [1] (30,099) [1] $ (31,749) [1] (49,073) (1,368)  
Total stockholder’s equity 96,458 49,107 [1] 29,870 [1] 49,107 [1] 96,458 [1] 250,830 33,887 $ 4,809
As Previously Reported [Member]                
Schedule of Restated Audited Consolidated Statement of Equity [Line Items]                
Additional paid-in capital, issuance of shares upon exercise of warrants for cash           16,265  
Issuance of common shares for loan settlement             3,383  
Issuance of new shares for cash             30,124  
Net loss attributable to common stockholders           (15,754)    
Net loss attributable to common stockholders (4,063) (4,540) [1] (3,548) [1] (8,088) [1] (12,151) [1] (15,754) (8,140)  
Total stockholder’s equity 105,951 55,859 [1] 49,869 [1] 55,859 [1] 105,951 [1] 269,833 41,738  
Restatement Adjustment [Member]                
Schedule of Restated Audited Consolidated Statement of Equity [Line Items]                
Additional paid-in capital, issuance of shares upon exercise of warrants for cash           22,168 2,937  
Issuance of common shares for loan settlement             (2,083)  
Issuance of new shares for cash             (15,487)  
Net loss attributable to common stockholders           (33,319)    
Net loss attributable to common stockholders 2,413 3,985 [1] (25,996) [1] (22,011) [1] (19,598) [1] (33,320) 6,772  
Total stockholder’s equity (9,493) (6,752) [1] (19,999) [1] (6,752) [1] (9,493) [1] (19,003) (7,851)  
Additional Paid-in Capital [Member]                
Schedule of Restated Audited Consolidated Statement of Equity [Line Items]                
Additional paid-in capital, issuance of shares upon exercise of warrants for cash   18,110 20,406   38,514      
Issuance of common shares for loan settlement             1,300  
Total stockholder’s equity 129,439 80,401 [1] 60,590 80,401 [1] 129,439 [1] 300,701 35,044 4,602
Additional Paid-in Capital [Member] | As Previously Reported [Member]                
Schedule of Restated Audited Consolidated Statement of Equity [Line Items]                
Additional paid-in capital, issuance of shares upon exercise of warrants for cash   8,794 8,064 16,858 16,858      
Total stockholder’s equity 126,114 71,913 [1] 61,366 71,913 [1] 126,114 [1] 293,156 49,667  
Additional Paid-in Capital [Member] | Restatement Adjustment [Member]                
Schedule of Restated Audited Consolidated Statement of Equity [Line Items]                
Additional paid-in capital, issuance of shares upon exercise of warrants for cash   9,316 12,342 21,656 21,656      
Total stockholder’s equity 3,325 8,488 [1] (776) 8,488 [1] 3,325 [1] 7,545 (14,623)  
Retained Earnings [Member]                
Schedule of Restated Audited Consolidated Statement of Equity [Line Items]                
Issuance of common shares for loan settlement              
Total stockholder’s equity (32,917) (31,267) [1] (30,711) [1] (31,267) [1] (32,917) [1] (50,241) (1,167) $ 201
Retained Earnings [Member] | As Previously Reported [Member]                
Schedule of Restated Audited Consolidated Statement of Equity [Line Items]                
Total stockholder’s equity (20,099) (16,027) [1] (11,487) [1] (16,027) [1] (20,099) [1] (23,693) (7,939)  
Retained Earnings [Member] | Restatement Adjustment [Member]                
Schedule of Restated Audited Consolidated Statement of Equity [Line Items]                
Total stockholder’s equity $ (12,818) $ (15,240) [1] $ (19,224) [1] $ (15,240) [1] $ (12,818) [1] $ (26,548) $ 6,772  
[1] Represents the downstream effects of the identified restatement adjustments and other individually immaterial changes.